Trials / Completed
CompletedNCT00644917
Clinical Evaluation of the Phototoxic Potential of Xenaderm Ointment
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 38 (actual)
- Sponsor
- Healthpoint · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The product is being tested to see if exposure to light causes toxic reactions on the skin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Xenaderm | 20mg under Finn chambers |
| DRUG | Placebo | 20mg under Finn chambers |
Timeline
- Start date
- 2008-02-01
- Primary completion
- 2008-02-01
- Completion
- 2008-02-01
- First posted
- 2008-03-27
- Last updated
- 2014-01-13
- Results posted
- 2014-01-13
Source: ClinicalTrials.gov record NCT00644917. Inclusion in this directory is not an endorsement.